Majid Soleimani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Majid Soleimani has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Majid Ghahraman Afshar
Imam Khomeini International University
8 shared publications Azam Khani
Imam Khomeini International University (IKIU)
4 shared publications- Samira Jafari
Department of Chemistry, Imam Khomeini International University (IKIU), Qazvin, Iran
3 shared publications - Ali Es-Haghi
Department of Physico Chemistry, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran
2 shared publications - Ali Rezaei Mokarram
Department of Adjuvant and formulation Research, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), P.O. Box 31975/148, Karaj, Iran
2 shared publications Marjan Hematyar
A Department of Chemistry , Imam Khomeini International University (IKIU) , Qazvin , Iran
2 shared publications
Latest Publications
- 15 December 2025
- Published by Springer Nature in Journal of Polymer Research
- Vol. 32 (12) , 477
Stimuli responsive polymeric micelles for combinational delivery and quantification of methotrexate and ciprofloxacin based on high performance liquid chromatography
- 15 December 2025
- Published by Springer Nature in Journal of Polymer Research
- Vol. 32 (12) , 477
Stimuli responsive polymeric micelles for combinational delivery and quantification of methotrexate and ciprofloxacin based on high performance liquid chromatography
- 24 January 2021
- Published by Springer Nature in Polymer Bulletin
- Vol. 79 (2) , 1021-1038
Application of different mathematical models for further investigation of in vitro drug release mechanisms based on magnetic nano-composite
- 24 January 2021
- Published by Springer Nature in Polymer Bulletin
- Vol. 79 (2) , 1021-1038
Application of different mathematical models for further investigation of in vitro drug release mechanisms based on magnetic nano-composite
- 1 September 2019
- Published by Elsevier in Journal of Chromatography A
- Vol. 1602, 30-40
Characterization and performance evaluation of functional monomer effect on molecular imprinted polyurethane foam
- 1 September 2019
- Published by Elsevier in Journal of Chromatography A
- Vol. 1602, 30-40
Characterization and performance evaluation of functional monomer effect on molecular imprinted polyurethane foam
- 30 May 2019
- Published by Springer Nature in Geotechnical and Geological Engineering
- Vol. 37 (6) , 5097-5111
Small Strain Shear Modulus Equations for Zeolite–Cement Grouted Sands
- 30 May 2019
- Published by Springer Nature in Geotechnical and Geological Engineering
- Vol. 37 (6) , 5097-5111
Small Strain Shear Modulus Equations for Zeolite–Cement Grouted Sands
- 12 November 2018
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 46 (sup3) , 1226-1235
Synergistic co-delivery of doxorubicin and melittin using functionalized magnetic nanoparticles for cancer treatment: loading and in vitro release study by LC–MS/MS
In this study, citric acid-functionalized Fe3O4 magnetic nanoparticles (CA-MNPs) were prepared via a coprecipitation method and were fully characterized. Doxorubicin (DOX) and melittin (MEL), as anticancer agents, were loaded onto CA-MNPs surface through electrostatic interactions with the aim to achieve an effective co-delivery system for cancer therapy. The loading efficiency and in vitro release profiles of DOX and MEL were investigated by liquid chromatography–tandem mass spectrometry (LC–MS/MS). The MS/MS step was performed in the selected reaction monitoring (SRM) mode which enabled simultaneous quantification of the analytes with high specificity and sensitivity. An excellent loading efficiency of about 100% was achieved for DOX and MEL in a drug to nanocarrier ratio of 1:10. The in vitro release of the drugs from CA-MNPs was evaluated for 8 h at pH 7.4, 5.5 and 4.5. The experimental results revealed that the release behaviour of both of the anticancer agents was strongly pH-dependent and significantly enhanced at pH 4.5. The in vitro MTT assay on MCF-7 breast cancer cell line exhibited a synergistic effect between DOX and MEL which led to substantially greater antitumor efficacy, compared to single administration of these anticancer agents at equivalent doses. The results indicated that the co-delivery system of (DOX/MEL)-loaded CA-MNPs is highly capable to be used in magnetically targeted cancer therapy.
- 12 November 2018
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 46 (sup3) , 1226-1235
Synergistic co-delivery of doxorubicin and melittin using functionalized magnetic nanoparticles for cancer treatment: loading and in vitro release study by LC–MS/MS
In this study, citric acid-functionalized Fe3O4 magnetic nanoparticles (CA-MNPs) were prepared via a coprecipitation method and were fully characterized. Doxorubicin (DOX) and melittin (MEL), as anticancer agents, were loaded onto CA-MNPs surface through electrostatic interactions with the aim to achieve an effective co-delivery system for cancer therapy. The loading efficiency and in vitro release profiles of DOX and MEL were investigated by liquid chromatography–tandem mass spectrometry (LC–MS/MS). The MS/MS step was performed in the selected reaction monitoring (SRM) mode which enabled simultaneous quantification of the analytes with high specificity and sensitivity. An excellent loading efficiency of about 100% was achieved for DOX and MEL in a drug to nanocarrier ratio of 1:10. The in vitro release of the drugs from CA-MNPs was evaluated for 8 h at pH 7.4, 5.5 and 4.5. The experimental results revealed that the release behaviour of both of the anticancer agents was strongly pH-dependent and significantly enhanced at pH 4.5. The in vitro MTT assay on MCF-7 breast cancer cell line exhibited a synergistic effect between DOX and MEL which led to substantially greater antitumor efficacy, compared to single administration of these anticancer agents at equivalent doses. The results indicated that the co-delivery system of (DOX/MEL)-loaded CA-MNPs is highly capable to be used in magnetically targeted cancer therapy.
- 10 October 2018
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 68 (14) , 859-869
Nanotechnology-based combinational drug delivery systems for breast cancer treatment
Modern chemotherapeutic anticancer treatments have come a long way in the fight against breast cancer, thus bringing science closer to a cure. However, the nature of these drugs is to attack both cancerous and non-cancerous cells at the same time. In our studies, we synthesized Magnetic Cyclodextrin-polyurethane based nano-composite (Fe3O4-ECA-PU-CD) which is a drug delivery system using a biocompatible magnetic polymer that directs chemotherapeutic drugs to cancerous regions in the body with an external magnet. This nano-composite was able to facilitate the loading and simultaneous release of the hydrophilic antitumor drug Doxorubicin (DOX) along with the hydrophobic antitumor drug docetaxel. The composite was made using a simple co-precipitation method with magnetic nano-particles (MNPs) followed by a silica coating process and an in situ polymerization process. Verification of synthesis for the drug carrier was carried out using techniques such as scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), Thermogravimetric Analysis (TGA), and a vibrating sample magnetometer (VSM) to measure magnetic properties. Drug loading and release efficiencies were monitored using an HPLC-UV detector. Finally, an MTT assay was performed in order to evaluate the biocompatibility and toxicity of the synthetic nano-composite on MCF7 cell lines. Our findings present a new biocompatible drug delivery system with a high capacity for loading and directing two different chemotherapeutic drugs simultaneously to cancer sites with little to no toxicity to the surrounding non-cancerous cells. These studies present a viable tool for cancer treatment and research where the cancer is efficiently removed while the patient remains healthy. Graphical Abstract
- 10 October 2018
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 68 (14) , 859-869
Nanotechnology-based combinational drug delivery systems for breast cancer treatment
Modern chemotherapeutic anticancer treatments have come a long way in the fight against breast cancer, thus bringing science closer to a cure. However, the nature of these drugs is to attack both cancerous and non-cancerous cells at the same time. In our studies, we synthesized Magnetic Cyclodextrin-polyurethane based nano-composite (Fe3O4-ECA-PU-CD) which is a drug delivery system using a biocompatible magnetic polymer that directs chemotherapeutic drugs to cancerous regions in the body with an external magnet. This nano-composite was able to facilitate the loading and simultaneous release of the hydrophilic antitumor drug Doxorubicin (DOX) along with the hydrophobic antitumor drug docetaxel. The composite was made using a simple co-precipitation method with magnetic nano-particles (MNPs) followed by a silica coating process and an in situ polymerization process. Verification of synthesis for the drug carrier was carried out using techniques such as scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), Thermogravimetric Analysis (TGA), and a vibrating sample magnetometer (VSM) to measure magnetic properties. Drug loading and release efficiencies were monitored using an HPLC-UV detector. Finally, an MTT assay was performed in order to evaluate the biocompatibility and toxicity of the synthetic nano-composite on MCF7 cell lines. Our findings present a new biocompatible drug delivery system with a high capacity for loading and directing two different chemotherapeutic drugs simultaneously to cancer sites with little to no toxicity to the surrounding non-cancerous cells. These studies present a viable tool for cancer treatment and research where the cancer is efficiently removed while the patient remains healthy. Graphical Abstract
- 29 September 2018
- Published by Springer Nature in Chromatographia
- Vol. 81 (11) , 1475-1486
Preparation of a New Polymerized Ionic Liquid-Modified Magnetic Nano Adsorbent for the Extraction and Preconcentration of Nitrate and Nitrite Anions from Environmental Water Samples
- 29 September 2018
- Published by Springer Nature in Chromatographia
- Vol. 81 (11) , 1475-1486
Preparation of a New Polymerized Ionic Liquid-Modified Magnetic Nano Adsorbent for the Extraction and Preconcentration of Nitrate and Nitrite Anions from Environmental Water Samples
- 27 July 2018
- Published by Springer Nature in Colloid and Polymer Science
- Vol. 296 (9) , 1581-1590
A sensitive nano-sensor based on synthetic ligand-coated CdTe quantum dots for rapid detection of Cr(III) ions in water and wastewater samples
- 27 July 2018
- Published by Springer Nature in Colloid and Polymer Science
- Vol. 296 (9) , 1581-1590
A sensitive nano-sensor based on synthetic ligand-coated CdTe quantum dots for rapid detection of Cr(III) ions in water and wastewater samples
- 3 October 2017
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 14 (12) , 2665-2671
Determination of trace amounts of nystatin in water and vaccine samples using sodium dodecyl sulfate-coated iron oxide magnetic nanoparticles followed by high-performance liquid chromatography–ultraviolet detection
- 3 October 2017
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 14 (12) , 2665-2671
Determination of trace amounts of nystatin in water and vaccine samples using sodium dodecyl sulfate-coated iron oxide magnetic nanoparticles followed by high-performance liquid chromatography–ultraviolet detection